Trial Profile
Phase IIb trial of ATL 1102 in patients with asthma.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Feb 2012
Price :
$35
*
At a glance
- Drugs ATL 1102 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Antisense Therapeutics
- 29 Feb 2012 New trial record